Working… Menu

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (PK-CIA-06)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01280240
Recruitment Status : Completed
First Posted : January 20, 2011
Last Update Posted : June 4, 2013
Information provided by (Responsible Party):
Pharmacosmos A/S

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2012
Actual Study Completion Date : November 2012